Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.

Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study

IAFRATE, MASSIMO
2014

Abstract

Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.
2014
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3170756
Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 47
social impact